Effects of Trp64Arg Mutation in the β3-Adrenergic Receptor Gene on Weight Loss, Body Fat Distribution, Glycemic Control, and Insulin Resistance in Obese Type 2 Diabetic Patients

  • Naoki Sakane
    Department of Internal Medicine, Kyoto Prefectural University of Medicine, Ayabe Municipal Hospital Kyoto, Japan
  • Toshihide Yoshida
    Department of Internal Medicine, Kyoto Prefectural University of Medicine, Ayabe Municipal Hospital Kyoto, Japan
  • Tsunekazu Umekawa
    Department of Internal Medicine, Kyoto Prefectural University of Medicine, Ayabe Municipal Hospital Kyoto, Japan
  • Akinori Kogure
    Department of Internal Medicine, Kyoto Prefectural University of Medicine, Ayabe Municipal Hospital Kyoto, Japan
  • Yasuto Takakura
    Department of Internal Medicine, Kyoto Prefectural University of Medicine, Ayabe Municipal Hospital Kyoto, Japan
  • Motoharu Kondo
    Department of Internal Medicine, Kyoto Prefectural University of Medicine, Ayabe Municipal Hospital Kyoto, Japan

抄録

<jats:sec> <jats:title>OBJECTIVE</jats:title> <jats:p>To investigate the effects of Trp64Arg mutation in the β3-adrenergic receptor gene on weight loss, body fat distribution, glycemic control, and insulin resistance in obese type 2 diabetic patients.</jats:p> </jats:sec> <jats:sec> <jats:title>RESEARCH DESIGN AND METHODS</jats:title> <jats:p>We measured body weight, waist-to-hip ratio (WHR), adjusted resting metabolic rate, fasting blood glucose, fasting serum insulin levels, insulin resistance index (fasting glucose × fasting insulin/22.5), and HbA1c levels before and after 12 weeks of obesity treatment in 61 obese women with type 2 diabetes. The Mval polymorphism of the β3-adrenergic receptor gene was determined by polymerase chain reaction-restriction fragment length polymorphism analysis.</jats:p> </jats:sec> <jats:sec> <jats:title>RESULTS</jats:title> <jats:p>Of obese type 2 diabetic patients, those with the mutation (n = 24) had a higher WHR (P &lt; 0.001), a lower adjusted metabolic rate, and higher blood glucose levels, serum insulin levels, insulin resistance index (P &lt; 0.001), and HbA1c levels (P = 0.016). Furthermore, patients with the mutation had smaller decreases in body weight, WHR, insulin resistance index, and HbA1c levels after the weight-loss program compared with patients without the mutation (n = 37), even though food intake, exercise, and serum thyroid hormone levels were similar in both groups.</jats:p> </jats:sec> <jats:sec> <jats:title>CONCLUSIONS</jats:title> <jats:p>These present findings show that the Trp64Arg allele of the β3-adrenergic receptor gene may predict difficulty in losing body weight, lowering WHR, and improving glycemic control and insulin resistance in obese patients with type 2 diabetes.</jats:p> </jats:sec>

収録刊行物

  • Diabetes Care

    Diabetes Care 20 (12), 1887-1890, 1997-12-01

    American Diabetes Association

被引用文献 (19)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ